Next-Gen Breakthroughs Transform Influenza Diagnostics
Key Growth Drivers and Opportunities
Global Awareness about Infectious Diseases: Global awareness about infectious diseases increases the demand for increasing, accurate, accurate and comprehensive testing. Recent experiences with epidemic such as public health campaigns, media coverage, and Covid-19 have increased the importance of the general population of viral transmission and timely diagnosis. As a result, the healthcare provider and the government are prioritizing investment in clinical infrastructure, rapid testing development and monitoring systems to prevent large -scale outbreaks. This awareness leads to maximum adoption of influenza diagnostic tools in hospitals, clinics, airports and even home settings, which promotes continuous market growth.
Challenges
Influenza diagnostics faces the high cost of advanced testing technologies in the market, low income and clinical equipment limited to clinical equipment in rural areas and the limits of variability in test accuracy-especially with antigen tests that may be false negative. Additionally, the seasonal nature of influenza may demand ups and downs, affecting continuous revenue creation and investment. Regulatory obstacles and skilled personnel need to be widely adopted to adopt molecular diagnosis.
Innovation and Expansion
Quest Diagnostics Gets CDC Contracts to Create Oropouche Virus and H5 Avian Flu Tests
In October 2024, leading diagnostic information services provider Quest Diagnostics announced that the U.S. Centers for Disease Control and Prevention (CDC) has awarded it multiple contracts to support testing and ongoing laboratory readiness for two newly discovered infectious diseases in the Americas.
By guaranteeing that a national commercial laboratory provider may promptly augment public health laboratories in the case of an infectious disease epidemic in humans, the agreements will enhance the country's readiness for avian influenza and Oropouche viruses.
The FDA Approves the First Over-the-Counter Flu and COVID-19 Test at Home
In February 2023, the first over-the-counter (OTC) at-home diagnostic test that can distinguish and identify influenza A and B, sometimes referred to as the flu, and SARS-CoV-2, the virus that causes COVID-19, was granted an emergency use authorization (EUA) by the U.S. Food and Drug Administration. A single-use at-home test kit, the Lucira COVID-19 & Flu Home Test yields findings from self-collected nose swab samples in around half an hour.
A single-use test for those exhibiting symptoms and indicators typical of a respiratory tract infection, including COVID-19, is the Lucira COVID-19 & Flu Home Test. The test is available without a prescription and may be done entirely at home with nose swab samples that people 14 years of age or older self-collect.
Inventive Sparks, Expanding Markets
Investing in major development strategies for influenza diagnostics manufacturers, investing rapidly and in multiplex test technologies, expanding at home and point-of-care test offerings, forming partnership with healthcare providers and governments, securing regulatory approval quickly and strengthening the global distribution network-in special emergence markets.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
TIME BUSINESS NEWS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
6 minutes ago
- Boston Globe
Ultra-processed foods make up over half of Americans' calories, CDC says
Youths consume more calories from the products than adults do — nearly 62 percent compared with 53 percent, according to the new report. Studies have identified industrially produced foods as risk factors for chronic diseases shortening lifespans in the United States. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up The CDC analyzed data collected from August 2021 to August 2023, and compared the results with a 10-year trend. Advertisement For those who criticize ultra-processed foods, there was one hopeful sign: People are beginning to consume fewer calories from them — a decline of 3.7 percent for youth and 3 percent for adults since 2017-2018. Kennedy has repeatedly said the nation's food supply is 'mass poisoning' this generation of children and made overhauling it one of his main priorities. A May report from the Trump administration's 'Make America Healthy Again' commission — which Kennedy chairs — identified the products as a core driver of chronic disease. A second report, aimed at offering detailed strategies for 'appropriately restructuring' the federal government's response to childhood disease, is due next week. Advertisement Ultra-processed foods are made up almost entirely of substances extracted from other foods or 'synthesized in laboratories' and typically contain many additives such as sugar, sodium, emulsifiers, and preservatives. Sandwiches (including burgers), sweet baked goods, savory snacks, and sweetened beverages were four of the top five sources of calories from ultra-processed foods among both youths and adults, according to the CDC report. The food industry has argued the demonization of ultra-processed foods oversimplifies the issue and ignores the reality of consumers' lives and their budgets. The industry has pointed to clear nutritional information as a key to helping people make healthier choices. Some nutritionists have said there's been confusion over the term that has led to the demonizing of ultra-processed products with some healthy nutrients, such as some sliced breads and yogurts. Kennedy's health agencies, along with the US Department of Agriculture, are seeking to refine the definition of 'ultra-processed.' The departments also plan to significantly revamp the nation's dietary guidelines, which are due later this year. While Kennedy's handling of vaccination policy and other issues have been controversial, his food messaging has found broader appeal as Americans struggle with weight and chronic disease. Roughly 20 percent of US children are obese, nearly four times the rate in the 1970s before the proliferation of ultra-processed foods. Among youths studied in the new CDC report, the calories from ultra-processed foods did not significantly differ based on family income. But for adults, those with the highest family income had less of their caloric intake come from such products. Jerold Mande, an adjunct professor of nutrition at Harvard T.H. Chan School of Public Health, said ultra-processed food is clearly making people sick. Advertisement 'The evidence is overwhelming,' said Mande, who previously served in senior food and nutrition policy positions at USDA and the Food and Drug Administration. 'What we don't know is exactly why.' A landmark study published six years ago provided some of the most compelling evidence to date that ultra-processed foods are harmful to Americans' health. Kevin Hall, a National Institutes of Health researcher who led the study, quit earlier this year, concerned about possible political interference by the Trump administration. The Department of Health and Human Services previously called Hall's fears of censorship a 'deliberate distortion of the facts.' Hall was involved in another study to identify the precise mechanisms that make such foods harmful. Meanwhile, the FDA and NIH have announced efforts aimed at accelerating nutrition research. Food companies have been accused of designing their products to be addictive and marketing them to children, including in a first-of-its-kind lawsuit filed last year. A March study by Hall and other researchers suggested ultra-processed foods are not addictive in the same way as certain illicit drugs. While some scientists say more research is needed, some food and addiction researchers are calling for the scientific community to recognize the addictive potential of ultra-processed foods. 'Although questions remain, recognizing addiction to ultra-processed food as a disorder — or, at minimum, as a condition in need of further study — paves the way toward improved prevention, clinical care, and policies,' four researchers, including Nora Volkow, the head of NIH's National Institute on Drug Abuse, wrote last month in Nature Medicine.
Miami Herald
24 minutes ago
- Miami Herald
Medicaid cuts set to drain revenue at elite teaching hospitals
Few in the U.S. healthcare sector are immune to the effects of Washington's recent cuts to Medicaid, even the cash-rich teaching hospitals affiliated with top-notch medical schools. These facilities, often known as academic medical centers or AMCs, are usually seen as the cream of the industry crop for their top-tier credit ratings and ability to churn out revenue. But federal cuts to the public health insurance program for low-income and disabled people will lead to less funding for teaching hospitals around the country. In response, they've already started to reduce staff and scale back operations. In June, Vanderbilt University Medical Center said it would lay off as many as 650 people. About 300 positions are being eliminated at the health system tied to the University of Pennsylvania, an Ivy League school. And just last week, the University of Vermont Health Network announced staff and spending cuts. Add in other industry challenges such as rising costs and labor shortages - which stretch back to the Covid-19 pandemic - and AMCs, once seen as a trophy, now look like a liability. 'It could be material potentially for individual credits,' said Brad Spielman, a vice president at Moody's Ratings, referring to Medicaid funding, which was cut by nearly $1 trillion over ten years. 'Money withdrawn is money withdrawn.' The risk to AMCs is a drop in revenue as some patients lose Medicaid coverage and reimbursements for their care decline. That could spell trouble for schools with teaching hospitals. Medical facilities contributed 45% of their total revenue in fiscal 2023, according to a Moody's report. For universities, that income from their medical centers can be 'very good in the good times and not so great in the bad times,' said Patrick Ronk, an analyst covering higher education at Moody's. In recent years, some AMCs have increased their exposure to Medicaid patients by acquiring community hospitals in deals meant to expand their networks and boost income. Members of the Association of American Medical Colleges - which includes AMCs, medical schools and academic societies - make up just 5% of the nation's hospitals but provide about 27% of Medicaid hospitalizations. AMCs won't just be affected by Medicaid cuts, which will be phased in over the next few years. The Trump administration has also frozen billions in research grants and moved to scale back other federal support, which will also put a strain on operations, according to Leonard Marquez, who oversees government relations and advocacy at the Association of American Medical Colleges. It adds up to 'death by a thousand cuts,' Marquez said. 'I've never seen a situation where we have so many different lines of attack coming at us.' Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Fox News
an hour ago
- Fox News
Could chikungunya virus spread to US? Here's what Americans should know
A mosquito-borne virus has led to a widespread outbreak in China – but could it show up in the U.S.? The U.S. Centers for Disease Control and Prevention (CDC) issued a Level 2 alert on Wednesday for an outbreak of chikungunya virus in the Guangdong Province, where health officials have reported more than 7,000 cases, per the Associated Press (AP). There are efforts underway to control the mosquitoes spreading the virus, including the use of nets, insecticide and drones, the report stated. Chikungunya cases have also been spreading throughout Europe, according to the European Centre for Disease Prevention and Control (ECDC). The virus is transmitted when a mosquito feeds on an infected person and then bites someone else. Dr. Paul Sax, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital in Boston, said an outbreak in the U.S. is unlikely. Chikungunya is a predominantly tropical virus spread through Aedes mosquitoes, which can be found in the southern United States. "The reason why we don't have lots of chikungunya, dengue or Zika in the United States is that there isn't that many of those mosquitoes here," Sax said. "To really sustain an outbreak of chikungunya in the United States, you need to have a lot more people with chikungunya. And we only occasionally have people with that." "If there isn't very much circulating chikungunya in our community, we're not going to see a sustained epidemic." It is mainly Americans who have recently traveled to highly endemic areas of the world who could potentially contract chikungunya, the expert noted — and then they would have to be bitten by mosquitoes that spread it to others. "So, it's very unlikely to have a big outbreak, but if we were to have an outbreak – it's most likely to occur in places like Florida, Louisiana and Texas," Sax said. There was a recent case of chikungunya at Brigham and Women's hospital involving a patient who had traveled to Bolivia, the doctor shared. "She contracted it there and then came back here and was diagnosed here," he said. "But that person then has to be bitten by an Aedes mosquito, which then transmits it to another person … If there isn't very much circulating chikungunya in our community, we're not going to see a sustained epidemic." Symptoms of the chikungunya virus typically include fever, headache and severe joint pain. The joint pain can last weeks or even months after the initial infection, Sax shared. There is no antiviral treatment for chikungunya, but some patients may see a joint specialist who can prescribe anti-inflammatory drugs. Over-the-counter anti-inflammatories like ibuprofen can also help relieve symptoms, according to Sax. Two vaccines also exist – IXCHIQ and VIMKUNYA – which are a popular choice for those who travel to highly endemic regions. Dr. Neil Maniar, Ph.D., professor of public health practice in the Department of Public Health & Health Sciences at Northeastern University in Boston, agreed that the risk of chikungunya in the U.S. is low. In a separate interview with Fox News Digital, Maniar suggested that the outbreak in China is most likely related to their monsoon season, as pests like mosquitoes and even ticks thrive in warm, wet environments. The expert encouraged people to take proper precautions when traveling or visiting tropical areas, even in the U.S. Those include using bug repellent, wearing long pants and receiving appropriate vaccinations when traveling to affected areas. "We're seeing an increase in illnesses that are transmitted by mosquitoes and ticks because we're seeing longer seasons where they can thrive," he said. "The population of mosquitoes and ticks is just growing … and I think that's something we should all pay attention to."
